article thumbnail

The Road Ahead for Private Equity: Reflections and Predictions

JD Supra: Mergers

The year 2023 will be remembered as a challenging one for private equity (PE), with complexities to navigate on many fronts. Although overall transaction volume was significantly down, private equity funds still found. By: Akin Gump Strauss Hauer & Feld LLP

article thumbnail

Federal Court Dismisses Antitrust Claims Against Private Equity Firm

JD Supra: Mergers

Private equity firms can breathe a sigh of relief after a federal judge dismissed claims that threatened to establish a precedent for holding private equity firms liable for certain actions by their portfolio companies. By: Troutman Pepper

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Trending Enforcement Targeting Private Equity Healthcare Portfolios Provides Important Compliance Reminder

JD Supra: Mergers

Over the last decade, private equity firms have acquired healthcare companies, hospitals, and clinics at an increasing rate. In fact, in those ten years, private equity firms have spent roughly $1 trillion on an estimated 8,000 healthcare deals. This trend is only expected to increase through 2024.

article thumbnail

The Role of Private Equity Consulting in Portfolio Company Growth Strategies

OfficeHours

Private equity consulting firms play a crucial role in the success of portfolio companies by providing specialized expertise and strategic guidance. Private equity consulting firms go beyond traditional advisory services by providing value-added services to their clients.

article thumbnail

Recent Ruling Shows Healthcare Private Equity Firms a Path Through the New Antitrust Era

JD Supra: Mergers

Private equity sponsors can exhale: A federal court recently stopped the Federal Trade Commission's (FTC) antitrust action that targeted private equity sponsor Welsh, Carson, Anderson & Stowe for the healthcare "roll-up" strategy of its anesthesia practice management portfolio company. Anesthesia Partners, Inc.

article thumbnail

FTC Sues Private Equity Firm, Portfolio Company Over Anesthesiology Roll-Up Strategy

JD Supra: Mergers

21, 2023, sued a private equity firm in the U.S. The Federal Trade Commission (FTC) on Sept. District Court for the Southern District of Texas over an alleged decade-long "roll-up" strategy to consolidate anesthesiology practices in Texas. By: Holland & Knight LLP

article thumbnail

How Private Equity Firms Select Investment Targets and Build Capital: Insights for Entrepreneurs

JD Supra: Mergers

What do private equity and growth capital investors look for when adding new companies to their portfolio, and what strategies do they apply to help those companies optimize capital? They covered the current private equity landscape, strategies for creating value, industry trends, various investment structures, and more.